Bioprocess/chemical engineer with background in cell culture, molecular biology, cancer, microscopy, and data analysis. Currently at Ultragenyx Pharmaceuticals (formerly Dimension Therapeutics) working on upstream bioprocess scale-up and process development for rare disease AAV gene therapies.
Director, Upstream Process Development, Gene Therapy at Ultragenyx Pharmaceutical Inc.
PhD, Chemical Engineering